Analyst Ratings for Liminal BioSciences, Inc. (LMNL) [Neutrals]

LMNL Rating Summary

LMNL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LMNL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $16.50 (+337.7%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
Like LMNL Ratings? Also take a look at ADMA, CERS, XBIT, IBIO

LMNL Ratings News